Stonepine Capital Management, LLC Ovid Therapeutics Inc. Transaction History

Stonepine Capital Management, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 10, 2022	SELL	$1.85 - $2.26 $3.6 Million - $4.4 Million	-1,947,257 Reduced 55.83%	1,540,671 $2.84 Million
Q2 2022 Aug 12, 2022	SELL	$1.69 - $3.31 $1.23 Million - $2.42 Million	-730,141 Reduced 17.31%	3,487,928 $7.5 Million
Q1 2022 May 16, 2022	BUY	$2.65 - $3.49 $561,492 - $739,475	211,884 Added 5.29%	4,218,069 $13.2 Million
Q4 2021 Feb 14, 2022	BUY	$3.13 - $3.73 $2.36 Million - $2.81 Million	753,293 Added 23.16%	4,006,185 $12.9 Million
Q3 2021 Nov 12, 2021	BUY	$3.31 - $4.04 $4.15 Million - $5.06 Million	1,252,892 Added 62.64%	3,252,892 $10.9 Million

Q2 2021 Aug 16, 2021	SELL	$3.3 - $4.49 $1.59 Million - $2.17 Million	-483,059 Reduced 19.45%	2,000,000 $7.82 Million
Q1 2021 May 14, 2021	BUY	$2.42 - $4.47 $6.01 Million - $11.1 Million	2,483,059 New	2,483,059 $9.98 Million

43.2M

5.9K

300

Ticker OVID
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,419,400
Market Cap $52.8M
Description
Ovid Therapeutics Inc., a biopharmaceutical company, develops impactful medicines for patients and families with neurological disorders in the United States. The company is developing OV101, a drug candidate, which is in Phase 2A clinical trials for the treatment of fragile X syndrome; OV329, a GABA aminotransferase inhibitor for the treatment o...

Get notified when there are updates to the investment portfolio of Stonepine Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Stonepine Capital Management, LLC with notifications on news.